Russell Investments Group, Ltd. Verastem, Inc. Transaction History

Russell Investments Group, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	BUY	$0.92 - $11.16 $132,748 - $1.61 Million	144,292 Added 52.81%	417,514 $353,000
Q2 2022 Jul 29, 2022	BUY	$1.02 - $1.83 $278,686 - $499,996	273,222 New	273,222 $316,000
Q1 2022 May 05, 2022	SELL	$1.06 - $2.1 $3,317 - $6,573	-3,130 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$2.05 - $3.2 $10,135 - $15,820	-4,944 Reduced 61.23%	3,130 $6,000
Q3 2021 Nov 08, 2021	SELL	$2.54 - $4.07 $384,921 - $616,784	-151,544 Reduced 94.94%	8,074 $24,000
Q2 2021 Aug 04, 2021	SELL	$2.57 - $4.85 $33,651 - $63,505	-13,094 Reduced 7.58%	159,618 $648,000
Q1 2021 May 10, 2021	BUY	$1.9 - $2.82 $270,938 - $402,129	142,599 Added 473.55%	172,712 $426,000
Q4 2020 Feb 08, 2021	BUY	$1.15 - $2.4 $34,629 - $72,271	30,113 New	30,113 $64,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $838M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.